Table 1.
Patients analyzed in the study
| Patients | Gender | Age at diagnosis | Histopathology |
| Family 1 (FAP1) | |||
| 01A | Female | 23 | FAP |
| 01B | Female | 25 | FAP |
| 01C | Female | 18 | FAP |
| 01D | Male | 14 | FAP |
| 01E | Male | 17 | FAP |
| Family 2 (FAP2) | |||
| 02F | Female | 40 | FAP |
| 02G | Male | 1 | FAP |
| 02H | Female | 15 | FAP |
| 02I | Male | NA2 | - |
| Family 3 (FAP3) | |||
| 03J | Male | 30 | FAP |
| 03H | Female | NA | - |
| 03L | Female | NA | - |
| 03M | Female | NA | - |
| Family 4 (FAP4) | |||
| 04N | Male | 40 | FAP |
| Family 5 (FAP5) | |||
| 05O | Male | 25 | FAP |
1
Unknown;
2
Patients without disease. FAP: Familial adenomatous polyposis; NA: Not applicable.